The Chemours Company
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-386.0M | $69.0M | $-253.0M | $578.0M | $608.0M | $219.0M | $-52.0M | $995.0M |
| Depreciation & Amortization | $340.0M | $292.0M | $309.0M | $291.0M | $317.0M | $320.0M | $311.0M | $284.0M |
| Depreciation | $340.0M | $301.0M | $297.0M | $286.0M | $309.0M | $313.0M | $304.0M | $276.0M |
| Amortization | $1.0M | $1.0M | $10.0M | $5.0M | — | — | — | — |
| Stock-Based Compensation | $21.0M | $15.0M | $18.0M | $27.0M | $34.0M | $16.0M | $19.0M | $24.0M |
| Net Cash from Operating Activities | $264.0M | $-633.0M | $556.0M | $755.0M | $814.0M | $807.0M | $650.0M | $1.14B |
| Investing Activities | ||||||||
| Capital Expenditures | $213.0M | $360.0M | $370.0M | $307.0M | $277.0M | $267.0M | $481.0M | $498.0M |
| Business Acquisitions | — | — | — | — | $0 | $0 | $10.0M | $37.0M |
| Net Cash from Investing Activities | $-206.0M | $-353.0M | $-229.0M | $-284.0M | $220.0M | $-234.0M | $-483.0M | $-487.0M |
| Financing Activities | ||||||||
| Dividends Paid | $78.0M | $148.0M | $149.0M | $154.0M | $164.0M | $164.0M | $164.0M | $148.0M |
| Stock Repurchases | — | — | $69.0M | $495.0M | $173.0M | $0 | $322.0M | $644.0M |
| Net Cash from Financing Activities | $-126.0M | $-36.0M | $172.0M | $-686.0M | $-554.0M | $-449.0M | $-419.0M | $-993.0M |
| Net Change in Cash | $-39.0M | $-1.04B | $503.0M | $-247.0M | $446.0M | $162.0M | $-258.0M | $-355.0M |
| Free Cash Flow | $51.0M | $-993.0M | $186.0M | $448.0M | $537.0M | $540.0M | $169.0M | $642.0M |